International Congress of Hyperthermic Oncology

International Congress of Hyperthermic Oncology

04/15/2016, New Orleans, United States

Hyperthermic Oncothermia is present internationally at congresses and conferences. Thus, in these scientific meetings, doctors give presentations to disseminate the results of clinical cases. Therefore, in this blog, we will inform about the events that take place, such as the following International Congress:

International Congress of Hyperthermic Oncology

Oncothermia is present internationally in congresses and conferences. In these scientific meetings doctors make presentations to disseminate the results of clinical cases. In this blog, we will inform about the events that take place.

On April 15, 2016 in New Orleans, United States, took place the International Congress of Hyperthermic Oncology (12th International Congress of Hyperthermic Oncology). In the United States, Hyperthermia is mainly applied in Oncology as a coadjuvant treatment. In the Congress presented results of the effect of Oncothermia with precise doses of radiotherapy (“Stereotaxis”) with excellent results.

Many interesting posters were presented. It is worthy of mention the presentations of: Dr. Michael Jackson of Canada and Dr. Heui-Kwan Lee of Korea.

  • Dr. Michael Jackson, et.a.:A preliminary in vitro evaluation of oncothermia on a normal and cancerous cell line.
  • Dr. Heui-Kwan Lee, et.al.: Iron-dextran as an ideal thermosensitizer in the radiofrequency-induced hyperthermia

Finally, if you want more information about the events related to Oncothermia treatment, you can visit the following website.

International Lungcancer Symposium

International Lungcancer Symposium

Oncothermia is an adjuvant method for the treatment of cancers, as in the case of Lung Cancer. It stands out for being a non-invasive method that can be combined with radiotherapy and chemotherapy.

Oncothermia is present internationally in congresses and conferences. In these scientific meetings doctors make presentations to disseminate the results of clinical cases.

2nd International Symposium on lung cancer

On April 17, 2016, in Budapest, the 2nd International Symposium on Lung Cancer took place (2nd International Lungcancer Symposium). The conference was organized in different sections. Professor Szasz directed the section: “Oncothermia in Advanced Lung Cancer”, where he presented his latest research and clinical results.

,

Oncothermia receives the patent as a “tumor vaccine”

Oncothermia como patente cáncer

Oncothermia receives the patent as a “tumor vaccine”

This treatment alerts our immune system by checking the cancer cells.

The Oncothermia EHY-2000 plus device received the patent, US 20150217099 A1 in August 2015, describing this treatment as “a tumor vaccine”. It refers to “a vaccine” because it stimulates the immune system and radiofrequency promotes apoptosis or cell death of tumor cells.

Oncothermia is effective for the primary tumor and its metastases. Therefore, it has a local and systemic effect.

Procedure of action of the “vaccine”

The applied technique is called Modulated Electro-Hyperthermia (mEHT). The cancer cells in our body when treated with mEHT produce “heat shock proteins” when they are heated. This treatment alerts our immune system by checking the cancer cells. In this way, these cells are recognized by our immune system and eliminate them.

We all have approximately 1000 cancer cells that circulate in our body every day. Those with a weak immune system can develop a tumor.

In conclusion

For patients diagnosed with cancer, Oncothermia is an excellent option for immunotherapy to complement conventional treatments: surgery, chemotherapy or radiotherapy, in an integrative oncology framework.

You can obtain more information about the operation of Oncothermia for treatments in cancer patients through this link.

,

Oncothermia at the Congress of Radiotherapy Technicians (10-12 / 11/2017, Lisbon, Portugal)

Oncothermia at the Congress of Radiotherapy Technicians (10-12 / 11/2017, Lisbon, Portugal)

Filipe Cidade de Moura and Prof.András Szász

Oncothermia is an adjuvant treatment for cancer. It is present at an international level at events such as this congress and other conferences. At these scientific meetings, doctors, technicians and healthcare personnel give presentations to disseminate the results of clinical cases.

Congress in Lisboa

Therefore, on November 10-12, 2017, in Lisbon, took place the Congress of Radiotherapy Technicians (Congresso 2017art).

The congress was organized in different sections. Professor Szasz led the talk “Immunological effects with Oncothermia“, where he presented his latest research and results. Also, he detailed his studies on Oncothermia and the results in relation to the inhibitory effect on the natural activity of the malignant cells. Among other things he highlighted the stimulation of the patient’s immune response.

Objective of the research

Most of the radiation therapies act locally. The local control of the tumor is usually not enough for elongation of the survival time because the malignancy is systemic. The abscopal effect, together with immune-stimuli could extend the local method to systemic and could be effective against macro- and micrometastases, too. Our objective is presenting the abscopal effect of modulated electro-hyperthermia (mEHT, oncothermia).

References

https://www.justnews.pt/documentos/2015/image/file/17e/ProgramaCNART-2017.pdf

http://oncotherm.com/en/news-events/congresso-2017-art-profandras-szasz-was-invited-hold-lecture